Literature DB >> 12529486

Cardiovascular vagosympathetic activity in rats with ventromedial hypothalamic obesity.

Paul Valensi1, Liliane Doaré, Gérard Perret, Renée Germack, Jacques Pariès, Didier Mesangeau.   

Abstract

OBJECTIVE: Rats with ventromedial hypothalamic lesion (VMH) are massively obese with endogenous hyperinsulinemia, insulin resistance, low sympathetic activity, and high parasympathetic activity, which are likely to induce hypertension. The goal was to follow in this model the long-term hemodynamic changes and to investigate the role of autonomic nervous system and insulin resistance in these changes. RESEARCH METHODS AND PROCEDURES: Heart rate and blood pressure were monitored for 12 weeks after operation using a telemetric system in VMH and sham rats. Plasma catecholamines and heart beta-adrenoceptors were measured. Glucose tolerance was studied after an intravenous glucose injection and insulin sensitivity during a euglycemic hyperinsulinemic clamp test.
RESULTS: A marked bradycardia and only a mild increase in blood pressure occurred in VMH rats compared with sham animals. Response to autonomic-acting drugs showed an increase in heart vagal tone and responsiveness to a beta-agonist drug. Plasma catecholamine levels were markedly increased, and the density and affinity of heart beta-adrenoceptors were similar in VMH, sham, and control rats. Muscle glucose use was reduced by 1 week after operation in VMH animals. DISCUSSION: These results show the following in this model of massively obese rats with sympathetic impairment: 1). adrenal medulla secretion is increased, probably as a result of hyperinsulinemia and increased vagal activity; 2). cardiac responsiveness to beta-agonist stimulation is increased; and 3). despite these changes and suspected resistance to the vasodilative effect of insulin, blood pressure does not increase. We conclude that high vagal activity may be protective against hypertension associated with obesity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12529486     DOI: 10.1038/oby.2003.10

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  8 in total

1.  Growth hormone enhances the recovery of hypoglycemia via ventromedial hypothalamic neurons.

Authors:  Isadora C Furigo; Gabriel O de Souza; Pryscila D S Teixeira; Dioze Guadagnini; Renata Frazão; Edward O List; John J Kopchick; Patricia O Prada; Jose Donato
Journal:  FASEB J       Date:  2019-07-31       Impact factor: 5.191

2.  Hypothalamic stimulation enhances hippocampal BDNF plasticity in proportion to metabolic rate.

Authors:  Zhe Ying; Alejandro Covalin; Jack Judy; Fernando Gomez-Pinilla
Journal:  Brain Stimul       Date:  2012-02-22       Impact factor: 8.955

3.  Beta oxidation in the brain is required for the effects of non-esterified fatty acids on glucose-induced insulin secretion in rats.

Authors:  C Cruciani-Guglielmacci; A Hervalet; L Douared; N M Sanders; B E Levin; A Ktorza; C Magnan
Journal:  Diabetologia       Date:  2004-11-30       Impact factor: 10.122

Review 4.  Autonomic nervous system activity changes in patients with hypertension and overweight: role and therapeutic implications.

Authors:  Paul Valensi
Journal:  Cardiovasc Diabetol       Date:  2021-08-19       Impact factor: 9.951

5.  Insulin- and glucagon-like peptide-1-induced changes in heart rate and vagosympathetic activity: why they matter.

Authors:  P Valensi; S Chiheb; M Fysekidis
Journal:  Diabetologia       Date:  2013-04-13       Impact factor: 10.122

Review 6.  Obesity-Induced Hypertension: Brain Signaling Pathways.

Authors:  Jussara M do Carmo; Alexandre A da Silva; Zhen Wang; Taolin Fang; Nicola Aberdein; Cecilia E P de Lara Rodriguez; John E Hall
Journal:  Curr Hypertens Rep       Date:  2016-07       Impact factor: 5.369

7.  Cardiac autonomic dysfunction is associated with hypothalamic damage in patients with childhood-onset craniopharyngioma.

Authors:  Hae Woon Jung; Hwa Young Kim; Ji Young Kim; Jung-Eun Cheon; In-One Kim; Seung-Ki Kim; Choong Ho Shin; Sei Won Yang; Young Ah Lee
Journal:  PLoS One       Date:  2021-02-16       Impact factor: 3.240

8.  Monosodium glutamate neonatal treatment induces cardiovascular autonomic function changes in rodents.

Authors:  Signorá Peres Konrad; Vera Farah; Bruno Rodrigues; Rogério Brandão Wichi; Ubiratan Fabres Machado; Heno Ferreira Lopes; Beatriz D'Agord Schaan; Kátia De Angelis; Maria Cláudia Irigoyen
Journal:  Clinics (Sao Paulo)       Date:  2012-10       Impact factor: 2.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.